Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-24-000150
Filing Date
2024-10-29
Accepted
2024-10-29 16:11:54
Documents
78
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20240927.htm   iXBRL 10-Q 1409841
2 EX-31.1 exel20240930exhibit31110-q.htm EX-31.1 9471
3 EX-31.2 exel20240930exhibit31210-q.htm EX-31.2 9451
4 EX-32.1 exel20240930exhibit32110-q.htm EX-32.1 7254
10 GRAPHIC exel-20240927_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-24-000150.txt   7519354

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20240927.xsd EX-101.SCH 50809
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20240927_cal.xml EX-101.CAL 70751
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20240927_def.xml EX-101.DEF 245625
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20240927_lab.xml EX-101.LAB 608811
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20240927_pre.xml EX-101.PRE 433616
81 EXTRACTED XBRL INSTANCE DOCUMENT exel-20240927_htm.xml XML 1160247
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0103
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 241405839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)